Komori
Other Disclosures330ATalentX Inc.Information and Communications, Services and Others

Industry-leading ウエルシア薬局 adopts integrated talent acquisition platform “MyTalent Platform” to transform its talent strategy in support of management strategy

ウエルシア薬局 added the recruitment CRM “MyTalent CRM” and recruitment branding CMS “MyTalent Brand” to the referral recruitment service it already uses. This enables the company to coordinate ongoing relationship-building with candidates and the dissemination of recruitment information.

Worth reading
60In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
300
Comments or more (cumulative employee recommendation comments)
Wording
Conditional
How definitive the wording is.

Announced details

MyTalent PlatformMyTalent CRMMyTalent BrandMyTalent Refer(MyRefer)
Applicable field (uses covered by this announcement)

Recruitment activities, talent pool recruitment, recruitment branding, referral recruitment, and relationship-building with candidates

Launch dateThe services are stated to have been adopted, but the specific start date is not disclosed.
What the company reported numerically
Quantitative Effects

More than 300 recommendation comments have been accumulated from employees.

Usage history

More than 300 employee recommendation comments accumulated

Relationship between the counterparty and the company
TalentX Inc.330A
Relationship with the Company

A business relationship in which ウエルシア uses our recruitment platform and its modules. ウエルシア had already adopted MyTalent Refer (MyRefer) and has now additionally adopted MyTalent CRM and MyTalent Brand.

Counterpartyウエルシア薬局株式会社

A leading company in the drugstore industry. It is pursuing a transition to “life stores” that serve as infrastructure for local communities. Other information on its location, representative, capital and year of establishment is not disclosed.

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredMyTalent Platform, MyTalent CRM, MyTalent Brand, MyTalent Refer(MyRefer)
Counterpartyウエルシア薬局株式会社
Counterparty overviewA leading company in the drugstore industry. It is pursuing a transition to “life stores” that serve as infrastructure for local communities. Other information on its location, representative, capital and year of establishment is not disclosed.
Relationship with the CompanyA business relationship in which ウエルシア uses our recruitment platform and its modules. ウエルシア had already adopted MyTalent Refer (MyRefer) and has now additionally adopted MyTalent CRM and MyTalent Brand.
Launch dateThe services are stated to have been adopted, but the specific start date is not disclosed.
Applicable areaRecruitment activities, talent pool recruitment, recruitment branding, referral recruitment, and relationship-building with candidates
Quantitative EffectsMore than 300 recommendation comments have been accumulated from employees.
Usage historyMore than 300 employee recommendation comments accumulated
Items this document does not state (10)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To attract high-quality candidates and improve recruitment efficiency, strengthen talent pool recruitment and recruitment branding, optimize recruitment marketing overall, and secure immediately effective talent.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Industry-leading ウエルシア薬局 adopts integrated talent acquisition platform “MyTalent Platform” to transform its talent strategy in support of management strategy | TalentX Inc. (330A) timely disclosure | Komori